Concepedia

Publication | Open Access

Pemafibrate Dramatically Ameliorated the Values of Liver Function Tests and Fibrosis Marker in Patients with Non-Alcoholic Fatty Liver Disease

DOIFull Paper Access

22

Citations

19

References

2020

Year

Suguru Ikeda, Takaaki Sugihara, Yoshiki Hoshino, Yukako Matsuki, Takakazu Nagahara, Jun‐ichi Okano, Sonoko Kitao, Youhei Fujioka, Kazuhiro Yamamoto, Hajime Isomoto
Yonago acta medica

Abstract

Pemafibrate dramatically ameliorated the values of liver function tests and APRI in patients with NAFLD.

References

YearCitations

Page 1